Posted by Michael Wonder on 24 Jan 2019
PhRMA blasts Trump’s plan to tie U.S. drug prices to other countries’ — but some of its criticisms don’t hold up
24 January 2019 - The pharmaceutical industry’s Washington lobbying group is fighting full force to scuttle a Trump administration policy proposal that would tie the price of drugs in the U.S. to their costs abroad — and making a handful of specious arguments along the way.
PhRMA has launched a multi-pronged attack against the proposal, arguing that it would, in effect, make health care in America more closely resemble systems in Europe.
Patients wouldn’t be able to get as many new drugs and might suffer as a result, they say.
